115 related articles for article (PubMed ID: 32887532)
41. TMPRSS4 is a type II transmembrane serine protease involved in cancer and viral infections.
Ohler A; Becker-Pauly C
Biol Chem; 2012 Sep; 393(9):907-14. PubMed ID: 22944691
[TBL] [Abstract][Full Text] [Related]
42. MDCK cells that express proteases TMPRSS2 and HAT provide a cell system to propagate influenza viruses in the absence of trypsin and to study cleavage of HA and its inhibition.
Böttcher E; Freuer C; Steinmetzer T; Klenk HD; Garten W
Vaccine; 2009 Oct; 27(45):6324-9. PubMed ID: 19840668
[TBL] [Abstract][Full Text] [Related]
43. TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium.
Bertram S; Dijkman R; Habjan M; Heurich A; Gierer S; Glowacka I; Welsch K; Winkler M; Schneider H; Hofmann-Winkler H; Thiel V; Pöhlmann S
J Virol; 2013 Jun; 87(11):6150-60. PubMed ID: 23536651
[TBL] [Abstract][Full Text] [Related]
44. Roles and regulation of membrane-associated serine proteases.
Qiu D; Owen K; Gray K; Bass R; Ellis V
Biochem Soc Trans; 2007 Jun; 35(Pt 3):583-7. PubMed ID: 17511657
[TBL] [Abstract][Full Text] [Related]
45. Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract.
Ortiz ME; Thurman A; Pezzulo AA; Leidinger MR; Klesney-Tait JA; Karp PH; Tan P; Wohlford-Lenane C; McCray PB; Meyerholz DK
EBioMedicine; 2020 Oct; 60():102976. PubMed ID: 32971472
[TBL] [Abstract][Full Text] [Related]
46. Potent and specific inhibition of the biological activity of the type-II transmembrane serine protease matriptase by the cyclic microprotein MCoTI-II.
Gray K; Elghadban S; Thongyoo P; Owen KA; Szabo R; Bugge TH; Tate EW; Leatherbarrow RJ; Ellis V
Thromb Haemost; 2014 Aug; 112(2):402-11. PubMed ID: 24696092
[TBL] [Abstract][Full Text] [Related]
47. TMPRSS2 Is the Major Activating Protease of Influenza A Virus in Primary Human Airway Cells and Influenza B Virus in Human Type II Pneumocytes.
Limburg H; Harbig A; Bestle D; Stein DA; Moulton HM; Jaeger J; Janga H; Hardes K; Koepke J; Schulte L; Koczulla AR; Schmeck B; Klenk HD; Böttcher-Friebertshäuser E
J Virol; 2019 Nov; 93(21):. PubMed ID: 31391268
[TBL] [Abstract][Full Text] [Related]
48. The tetraspanin CD9 facilitates MERS-coronavirus entry by scaffolding host cell receptors and proteases.
Earnest JT; Hantak MP; Li K; McCray PB; Perlman S; Gallagher T
PLoS Pathog; 2017 Jul; 13(7):e1006546. PubMed ID: 28759649
[TBL] [Abstract][Full Text] [Related]
49. Crosstalk between COVID-19 and prostate cancer.
Bahmad HF; Abou-Kheir W
Prostate Cancer Prostatic Dis; 2020 Dec; 23(4):561-563. PubMed ID: 32709978
[TBL] [Abstract][Full Text] [Related]
50. Probing the substrate specificities of matriptase, matriptase-2, hepsin and DESC1 with internally quenched fluorescent peptides.
Béliveau F; Désilets A; Leduc R
FEBS J; 2009 Apr; 276(8):2213-26. PubMed ID: 19302215
[TBL] [Abstract][Full Text] [Related]
51. Ligand-Based Design of Selective Peptidomimetic uPA and TMPRSS2 Inhibitors with Arg Bioisosteres.
Müller P; Zimmer C; Frey A; Holzmann G; Weldert AC; Schirmeister T
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338655
[TBL] [Abstract][Full Text] [Related]
52. Cleavage specificity analysis of six type II transmembrane serine proteases (TTSPs) using PICS with proteome-derived peptide libraries.
Barré O; Dufour A; Eckhard U; Kappelhoff R; Béliveau F; Leduc R; Overall CM
PLoS One; 2014; 9(9):e105984. PubMed ID: 25211023
[TBL] [Abstract][Full Text] [Related]
53. Serine Protease Inhibitors to Treat Lung Inflammatory Diseases.
El Amri C
Adv Exp Med Biol; 2021; 1304():215-226. PubMed ID: 34019272
[TBL] [Abstract][Full Text] [Related]
54. Type II Transmembrane Serine Proteases as Modulators in Adipose Tissue Phenotype and Function.
Wu Q; Li S; Zhang X; Dong N
Biomedicines; 2023 Jun; 11(7):. PubMed ID: 37509434
[TBL] [Abstract][Full Text] [Related]
55. Upamostat: a serine protease inhibitor for antiviral, gastrointestinal, and anticancer indications.
Plasse TF; Fathi R; Fehrmann C; McComsey GA
Expert Opin Investig Drugs; 2023; 32(12):1095-1103. PubMed ID: 37970658
[TBL] [Abstract][Full Text] [Related]
56. In Vitro Pharmacokinetic Behavior of Antiviral 3-Amidinophenylalanine Derivatives in Rat, Dog and Monkey Hepatocytes.
Lányi K; Monostory K; Steinmetzer T; Jerzsele Á; Pászti-Gere E
Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979660
[TBL] [Abstract][Full Text] [Related]
57. Harnessing the Potential of Enzymes as Inhaled Therapeutics in Respiratory Tract Diseases: A Review of the Literature.
Vanderstocken G; Woolf NL; Trigiante G; Jackson J; McGoldrick R
Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740461
[TBL] [Abstract][Full Text] [Related]
58. Novel Inhibitors and Activity-Based Probes Targeting Trypsin-Like Serine Proteases.
Ferguson TEG; Reihill JA; Martin SL; Walker B
Front Chem; 2022; 10():782608. PubMed ID: 35529696
[TBL] [Abstract][Full Text] [Related]
59. Yeast-Based Screening of Anti-Viral Molecules.
Srivastava V; Kumar R; Ahmad A
Microorganisms; 2024 Mar; 12(3):. PubMed ID: 38543629
[TBL] [Abstract][Full Text] [Related]
60. Suggestions in the Treatment of Diseases of the Respiratory Tract.
Jenkins JFT
Buffalo Med J; 1907 Jan; 62(6):345-348. PubMed ID: 36886739
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
